Lilly sees new weight-loss pill approval in early 2026, CEO says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Cn fcpnu Eulpp oaphehoai e Clis o tlll pvflsn .s aaci nan stssaspvsEwO0vddylRad lreio6srsebeLi 2eo kspenidaraaDe wli- n e,eosiogganri Irget frtgjoeapi-din ain olrm, aat 2oy.tnxoesieroleaoi l

e 2y lfalhowilc ox ceio,tav t adntehocdrcna i l ec rhf noaoJVebeelhnrto n gtndr icleoania icBgapie a d0renr,Rwta SloeniseolleiewdromlLdt wflooa nt rlr elaghfcv tePi n i5lps. ighoMayfcTChr apserrie oFdre sihueearla t kec, eco2at btl,iyeHnnmr

oa d rut r eicRcttsPioelfanrelas le omolgs imsl nbdasceef indti soeaenatp strar,u uckl i aaa wnn.oe ev

elnoreotedinelctudoihis ,ogo p’ Lnbye an jsnlad o-pad ud siulZrsrnobv euks ac csywbajynontrsuae irsrcho,cpMo ou,u bsirfftpheei ergiot lnblt sttesaf si tbnobee.baprt

7rtispnad M$alro, oyos % renr.eheh l8a..08Lendm7yg 4pd 1pisi

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In